Clinical Trial: A Clinical Trial to Compare Forms of MK-1167 in Healthy People (MK-1167-011)

U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07334860) titled 'A Clinical Trial to Compare Forms of MK-1167 in Healthy People (MK-1167-011)' on Dec. 31, 2025.

Brief Summary: Researchers are looking for new ways to treat Alzheimer's disease (AD). AD is a brain disease that causes a gradual decline in memory, thinking, and ability to carry out daily tasks. MK-1167 is a study medicine designed to treat symptoms of AD. Before giving a study medicine to people with a health condition, researchers first do studies in healthy people to find a safe dose of the study medicine.

The goals of the trial are to learn:

* What happens to different forms of MK-1167 in a healthy person's body over time

* Abou...